Epilepsia Open · 2021 · 28 citations · 57 references
MedicineNeurologyPharmacologyEpilepsyNeuroinfectious DiseasesNeuropharmacologyAnti-inflammatory PharmacologyAntiseizure MedicationsAntiviral PharmacologyEncephalitisAntiseizure Drug TrialsNew Antiseizure Drug DevelopmentNew Antiseizure Medication DevelopmentNovel Antiseizure MedicationsPharmacodynamics Of Antiseizure MedicationsPrevention Of Infection-related SeizuresSeizures
OBJECTIVE: Infection with Theiler's murine encephalomyelitis virus (TMEV) in C57Bl/6J mice results in handling-induced seizures and is useful for evaluating compounds effective against infection-induced seizures. However, to date only a few compounds have been evaluated in this model, and a comprehensive study of antiseizure medications (ASMs) has not yet been performed. Furthermore, as the TMEV infection produces marked neuroinflammation, an evaluation of prototype anti-inflammatory compounds is needed as well. METHODS: Male C57Bl/6J mice were inoculated with TMEV (day 0) followed by daily administrations of test compounds (day 3-7) and subsequent handling sessions (day 3-7). Doses of ASMs, comprising several mechanistic classes, were selected based on previously published data demonstrating the effect of these compounds in reducing seizures in the 6 Hz model of pharmacoresistant seizures. Doses of anti-inflammatory compounds, comprising several mechanistic classes, were selected based on published evidence of reduction of inflammation or inflammation-related endpoints. RESULTS: Several prototype ASMs reduced acute seizures following TMEV infection: lacosamide, phenytoin, ezogabine, phenobarbital, tiagabine, gabapentin, levetiracetam, topiramate, and sodium valproate. Of these, phenobarbital and sodium valproate had the greatest effect (>95% seizure burden reduction). Prototype anti-inflammatory drugs celecoxib, dexamethasone, and prednisone also moderately reduced seizure burden. SIGNIFICANCE: The TMEV model is utilized by the Epilepsy Therapy Screening Program (ETSP) as a tool for evaluation of novel compounds. Compounds reducing seizures in the TMEV comprise distinct mechanistic classes, some with mechanisms of action that extend beyond traditional ASMs.
57
Population-based study of the incidence of sudden unexplained death in epilepsy
David M. Ficker, E. L. So, Weilun Shen et al. · Neurology · 1998 · 462 citations
Seizure burden is independently associated with short term outcome in critically ill children
Eric T. Payne, Xiu Yan Zhao, Helena Frndova et al. · Brain · 2014 · 372 citations · Full text
Medicine, Neurology, Pediatrics +17